Singapore Institute of Advanced Medicine Holdings Ltd. (SGX:9G2)

Market Cap	31.44M
Revenue (ttm)	16.14M
Net Income (ttm)	-28.87M
Shares Out	1.05B
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	75,000
Average Volume	469,190
Open	0.0300
Previous Close	n/a
Day's Range	0.0300 - 0.0300
52-Week Range	0.0260 - 0.0900
Beta	n/a
RSI	48.34
Earnings Date	Oct 29, 2025

About SGXC:9G2

Singapore Institute of Advanced Medicine Holdings Ltd., an investment holding company, provides medical diagnostics and treatments, and radiation therapy and medical oncology services in Singapore. The company offers medical diagnostics and treatments, including cancer-related diagnostics and theranostics treatments, general diagnostics and health screening, and aesthetic services; and radiation therapy and medical oncology services comprise proton beam therapy, photon radiation therapy, and medical oncology services. It provides clinic and ima...

• Industry: Medical Laboratories
• Founded: 2011
• Country: Singapore
• Stock Exchange: Singapore Exchange - Catalist
• Ticker Symbol: 9G2

Financial Performance

In 2024, SGXC:9G2's revenue was 16.65 million, an increase of 2.54% compared to the previous year's 16.23 million. Losses were -37.45 million, 107.2% more than in 2023.